|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Real estate held for investment, at cost: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings and improvements | ||||||||||||||||||||
| Total real estate held for investment, at cost | ||||||||||||||||||||
| Less accumulated depreciation and amortization | ||||||||||||||||||||
| Real estate held for investment, net | ||||||||||||||||||||
| Real estate and lease intangibles held for sale, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Lease intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Investment in loans and financing receivables, net | ||||||||||||||||||||
| Investment in unconsolidated entities | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Lease intangible liabilities, net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Line of credit payable and commercial paper | ||||||||||||||||||||
| Revolving credit facilities and commercial paper | ||||||||||||||||||||
| Term loans, net | ||||||||||||||||||||
| Mortgages payable, net | ||||||||||||||||||||
| Notes payable, net | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| 6.000% Series A cumulative redeemable preferred stock and paid in capital, par value $0.01 per share, 69,900 shares authorized, 6,900 shares and no shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively, liquidation preference $25 per share | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock and paid in capital, par value $0.01 per share, 1,300,000 shares authorized, 946,202 and 933,975 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Distributions in excess of net income | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity |
Loading...
